03/07/2019
HemoHIM is a new substance with special immune function that has been developed from Angelica radix, Chuanxiong Rhizoma, and PaeoniaenAlba Radix through biological engineering and radiation technology.”
HemoHIM stands for:
Hemoglobin: Hemoglobin carries oxygen from the lungs to the rest of the body where it releases the oxygen to burn nutrients to provide energy to power the functions of the body in metabolism.
Hemopoiesis: The formation of blood.
Immune: Your Immune System.
Modulation: Regulate.
Basically, HemoHIM strengthens/regulates your immune system, help your body form fresh blood and hemoglobin. HemoHIM is patented in the United States as “Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage”. (United States Patent 06964785)
See HemoHIM US Patent: http://www.directorypatent.com/US/06964785.html
HemoHIM is a not a medicine, but a functional health supplement. It serves a special purpose of strengthening your immune system. And the main ingredients are quite exotic: Angelica radix, Chuanxiong Rhizoma, and PaeoniaenAlba Radix. These are herbs cultivated in the clean fields of South Korea, and were widely used in oriental herbal medicines for centuries.
DEVELOPMENT OF HEMOHIM
HemoHIM was the name of a government research project by a team of Ph.D. scientists at Korea Atomic Energy Research Institute (KAERI). The South Korean government proposed the project to create a new substance that will radically increase human immune system in order to protect the nation’s most valued scientists at KAERI, who have much higher chance of getting exposed to radiation compared to other people. The team tested more than 1,000 different kinds of herbs to create a perfect substance to accomplish the project’s objective. To do that, it took the team about 8 years and government assistant of more than 5 million dollars. At the finish of the project, the Korean government decided to commercialize the substance to offer it to the general public. The truth is, not only the scientists working with atomic energy is affected by radiation, but we are all exposed to radiation in our daily activities such as using cell phones! Then the project name HemoHIM became the substance/product name and was offered to the general public.
There are three main organizations/companies involved in the production of HemoHIM:
Korea Atomic Energy Research Institute (KAERI): Responsible for the research and development of the HemoHIM formula.
Kolmar BNH Co. Ltd. (SBT): Company responsible for making the actual substance with the formula provided by KAERI.
Atomy America Inc.: The only distributor of HemoHIM.
At first, Atomy wasn’t the distributor of HemoHIM. But the company who originally distributed HemoHIM sold it at $1,200 for one month’s supply. When the South Korean government found out about the ridiculous amount of profit the company was making, it seized its contract with the company because they violated the agreement to make HemoHIM readily available to common folks. After all, HemoHIM was developed using common folks’ tax money! The beauty of HemoHIM is that the ingredients are readily available in clean uncontaminated fields of South Korea. The three main ingredients were widely used for centuries as herbal medicines, but it is the research and and technology of KAERI that took ordinary herbs into such a substance. In fact, even if HemoHIM was so good,
The three main ingredients of HemoHIM are:
1. Angelicae gigantis Radix: Used for menstrual cramps, premenstrual syndrome (PMS), and menopausal symptoms. It is also used orally as a ”blood purifier”; to manage hypertension, infertility, joint pain, ulcers, “tired blood” (anemia), and constipation; and in the prevention and treatment of allergic attacks. D**g quai is also used orally for the treatment of loss of skin color (depigmentation) and psoriasis.
Angelicae Gigantis Radix regulates mast cell-mediated allergic inflammation in vivo and in vitro.
http://www.ncbi.nlm.nih.gov/pubmed/22705330
2. Cnidium officinale Makino
3. Paeonia japonica Miyabe et Takeda
HemoHIM is not just a product. It is a result of vigorous scientific research. Many scientists are referring HemoHIM in their professional scientific journals. There are currently 18 science journal literature about HemoHIM on US National Library of Medicine and National Institutes of Health alone.
Science Journal Literature About HemoHIM Found on PubMed:
PubMed is a service of the US National Library of Medicine® that Provides free access to databases of indexed citations and abstracts to medical, nursing, dental, veterinary, health care, and preclinical sciences journal articles.
Preventative effect of an herbal preparation (HemoHIM) on development of airway inflammation in mice via modulation of Th1/2 cells differentiation.
http://www.ncbi.nlm.nih.gov/pubmed/23844220
Protective effects of HemoHIM on immune and hematopoietic systems against γ-irradiation.
http://www.ncbi.nlm.nih.gov/pubmed/23595637
HemoHIM enhances the therapeutic efficacy of ionizing radiation treatment in tumor-bearing mice.
http://www.ncbi.nlm.nih.gov/pubmed/20136435
Screening of anti-obesity agent from herbal mixtures.
http://www.ncbi.nlm.nih.gov/pubmed/22447026
HemoHIM ameliorates the persistent down-regulation of Th1-like immune responses in fractionated γ-irradiated mice by modulating the IL-12p70-STAT4 signaling pathway.
http://www.ncbi.nlm.nih.gov/pubmed/22439601
Protective effect of an herbal preparation (HemoHIM) on radiation-induced intestinal injury in mice.
http://www.ncbi.nlm.nih.gov/pubmed/20041793
HemoHIM improves ovarian morphology and decreases expression of nerve growth factor in rats with steroid-induced polycystic ovaries.
http://www.ncbi.nlm.nih.gov/pubmed/20041792
Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice.
http://www.ncbi.nlm.nih.gov/pubmed/19292900
Restoration of the immune functions in aged mice by supplementation with a new herbal composition, HemoHIM.
http://www.ncbi.nlm.nih.gov/pubmed/17705143
Antiinflammatory activity of an herbal preparation (HemoHIM) in rats.
http://www.ncbi.nlm.nih.gov/pubmed/17486680
Science Journal Literature About HemoHIM Found on PMC:
PMC is a free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health’s National Library of Medicine (NIH/NLM).
Preventative Effect of an Herbal Preparation (HemoHIM) on Development of Airway Inflammation in Mice via Modulation of Th1/2 Cells Differentiation
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699527/
Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666758/
The Prospective Role of Plant Products in Radiotherapy of Cancer: A Current Overview
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253585/
Hyberbaric oxygen increases atresia in normal & steroid induced PCO rat ovaries
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395821/
Evaluation of Nephroprotective and Immunomodulatory Activities of Antioxidants in Combination with Cisplatin against Murine Visceral Leishmaniasis
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341342/
Protective effect of genistein on radiation-induced intestinal injury in tumor bearing mice
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671128/
Trends in Ginseng Research in 2010
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659559/
Preserved ex vivo inflammatory status and cytokine responses in naturally long-lived mice
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980596/
https://m.youtube.com/watch?v=r8xEYAl-9wo
